Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

CHANGES IN HIV TESTING SERVICES AFTER COVID-19 IN 11 SUB-SAHARAN AFRICAN COUNTRIES

By Jimmy He PharmD, DScApril 22, 2021

The COVID-19 pandemic has interrupted the implementation of many HIV prevention programs supported by the US President’s Emergency Plan for AIDS Relief (PEPFAR), especially in sub-Saharan Africa. We evaluated the…

HPV16-Specific T-Cell Responses and Spontaneous Regression of Anal Intraepithelial Neoplasia

By Enthusiast Inc MDSeptember 29, 2014

…study, 26 men had high grade disease at study entry a mean 1 year prior, of which 6 experienced spontaneous regression by the time these assays were performed. Five (83%)…

TLR7 AGONIST GS-9620 INCREASES IMMUNE-MEDIATED CLEARANCE OF HIV-INFECTED CELLS

By Enthusiast Inc MDFebruary 16, 2017

…HIV-infected patients were treated with GS-9620 in the presence or absence of HIV peptides. To assess the role of type I interferons in the effects mediated by GS-9620, an antibody…

506 – Sustained T Cell-Mediated Immunity After LS-bNAbs in the RIO Trial: A Vaccinal Effect

By Jimmy He PharmD, DScMarch 20, 2025

…gamma-interferon ELISPOT with HIV full genome 15-mer overlapping peptides, proliferation (Cell Trace Violet) and Activation Induced Marker (AIM) assays (CD25, OX40, 41BB, CD69), the latter two using pooled peptides (Gag,…

LONG-TERM OUTCOME IN HIV-1 INFECTED ADULTS WITH ADVANCED IMMUNODEFICIENCY

By Enthusiast Inc MDMarch 5, 2019

Prior to the President’s Emergency Plan for AIDS Relief (PEPFAR) Program, patients initiating antiretroviral treatment (ART) in resource-limited settings frequently had very advanced immunodeficiency. In this study, we examined CD4…

274 – Pre-ATI CD4+ T-Cell Immune Activation Capacity Identifies Postintervention Controllers

By Jimmy He PharmD, DScMarch 31, 2026

…less defined. Methods We studied 5 PICs (4 males, 1 female) with prolonged viral suppression (median 6 years, IQR 3.6-6.4) after analytical treatment interruption (ATI) following broadly neutralizing antibody therapy….

277 – The Microbiome of Exceptional Elite Controllers Linked to HIV-Specific Immune Responses

By Jimmy He PharmD, DScMarch 31, 2026

…metagenomes were analyzed for taxonomy (mOTUs3) and function (eggNOG-mapper). Inactivated fecal bacterial communities (FBC) and sterile filtrates (SF) were prepared. CP’s PBMCs were primed with SF or FBC, stimulated with…

EX-VIVO IMPACT OF LRAS AND SPECIFIC LIGANDS ON ESTROGEN RECEPTOR IN CD4+ T CELLS

By Jimmy He PharmD, DScMarch 3, 2023

…The breast cancer cell line T-47D was used as control and all experiments were performed in hormone-free media. Results: In contrast to T-47D breast cancer cells, in CD4+ T cells…

Ten Years of Strengthening Laboratory Services and Systems: Then, Now, and the Future

By Enthusiast Inc MDFebruary 24, 2015

The last 10 years have been transformational for laboratory medicine in Africa thanks to increase in global health funding, especially from the world bank, PEPFAR, the Global fund–etc. Laboratory networks…

EPITOPES ASSOCIATED WITH ALTERED PATHOGENESIS IN VERTICAL HIV-1 TRANSMISSION

By Jimmy He PharmD, DScApril 4, 2022

…summed the enrichments of the corresponding peptides for each strain. Binomial logistic regression of enrichment and maternal viral load was used to determine whether regional responses were associated with HIV…

←1
2345678910111213141516171819202122232425262728293031323334353637
…3839404142…
43444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top